UBE2L3 and lung adenocarcinoma: Additionally, UBE2L3 in promoting the migration and invasion of lung cancer cells (Ma et al. 2022), and can be used as a potential response biomarker to enhance the efficacy of HSP90 inhibitors against lung adenocarcinoma (Marrugal et al. 2023).